Functional screening of selective mitochondrial inhibitors of Plasmodium
Phenotypic screening has produced most of the new chemical entities currently in clinical development for malaria, plus many lead compounds active against Plasmodium falciparum asexual stages. However, lack of knowledge about the mode of action of these compounds delays and may even hamper their fut...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320717301203 |
id |
doaj-d31fe5e392d8459fb92b14da48cc417a |
---|---|
record_format |
Article |
spelling |
doaj-d31fe5e392d8459fb92b14da48cc417a2020-11-24T22:30:21ZengElsevierInternational Journal for Parasitology: Drugs and Drug Resistance2211-32072018-08-0182295303Functional screening of selective mitochondrial inhibitors of PlasmodiumMaria G. Gomez-Lorenzo0Ane Rodríguez-Alejandre1Sonia Moliner-Cubel2María Martínez-Hoyos3Noemí Bahamontes-Rosa4Rubén Gonzalez del Rio5Carolina Ródenas6Jesús de la Fuente7Jose Luis Lavandera8Jose F. García-Bustos9Alfonso Mendoza-Losana10Diseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, SpainCentro de Investigación Básica (CIB) GlaxoSmithKline, Tres Cantos, Madrid, SpainCentro de Investigación Básica (CIB) GlaxoSmithKline, Tres Cantos, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain; Department of Basic Medical Science, CEU San Pablo University, Julián Romea 23, 28003, Madrid, SpainDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain; Department of Microbiology and Biomedicine Discovery Institute, Monash University, 3800, VIC, AustraliaDiseases of the Developing World (DDW), Tres Cantos Medicine Development Campus, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain; Corresponding author. C/ Severo Ochoa, 2, Tres Cantos, 28760, Madrid, Spain.Phenotypic screening has produced most of the new chemical entities currently in clinical development for malaria, plus many lead compounds active against Plasmodium falciparum asexual stages. However, lack of knowledge about the mode of action of these compounds delays and may even hamper their future development. Identifying the mode of action of the inhibitors greatly helps to prioritise compounds for further development as novel antimalarials. Here we describe a whole-cell method to detect inhibitors of the mitochondrial electron transport chain, using oxygen consumption as high throughput readout in 384-well plate format. The usefulness of the method has been confirmed with the Tres Cantos Antimalarial Compound Set (TCAMS). The assay identified 124 respiratory inhibitors in TCAMS, seven of which were novel anti-plasmodial chemical structures never before described as mitochondrial inhibitors. Keywords: Plasmodium falciparum, Plasmodium yoelii, Oxygen consumption, Mitochondrial inhibitors and cytochromehttp://www.sciencedirect.com/science/article/pii/S2211320717301203 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria G. Gomez-Lorenzo Ane Rodríguez-Alejandre Sonia Moliner-Cubel María Martínez-Hoyos Noemí Bahamontes-Rosa Rubén Gonzalez del Rio Carolina Ródenas Jesús de la Fuente Jose Luis Lavandera Jose F. García-Bustos Alfonso Mendoza-Losana |
spellingShingle |
Maria G. Gomez-Lorenzo Ane Rodríguez-Alejandre Sonia Moliner-Cubel María Martínez-Hoyos Noemí Bahamontes-Rosa Rubén Gonzalez del Rio Carolina Ródenas Jesús de la Fuente Jose Luis Lavandera Jose F. García-Bustos Alfonso Mendoza-Losana Functional screening of selective mitochondrial inhibitors of Plasmodium International Journal for Parasitology: Drugs and Drug Resistance |
author_facet |
Maria G. Gomez-Lorenzo Ane Rodríguez-Alejandre Sonia Moliner-Cubel María Martínez-Hoyos Noemí Bahamontes-Rosa Rubén Gonzalez del Rio Carolina Ródenas Jesús de la Fuente Jose Luis Lavandera Jose F. García-Bustos Alfonso Mendoza-Losana |
author_sort |
Maria G. Gomez-Lorenzo |
title |
Functional screening of selective mitochondrial inhibitors of Plasmodium |
title_short |
Functional screening of selective mitochondrial inhibitors of Plasmodium |
title_full |
Functional screening of selective mitochondrial inhibitors of Plasmodium |
title_fullStr |
Functional screening of selective mitochondrial inhibitors of Plasmodium |
title_full_unstemmed |
Functional screening of selective mitochondrial inhibitors of Plasmodium |
title_sort |
functional screening of selective mitochondrial inhibitors of plasmodium |
publisher |
Elsevier |
series |
International Journal for Parasitology: Drugs and Drug Resistance |
issn |
2211-3207 |
publishDate |
2018-08-01 |
description |
Phenotypic screening has produced most of the new chemical entities currently in clinical development for malaria, plus many lead compounds active against Plasmodium falciparum asexual stages. However, lack of knowledge about the mode of action of these compounds delays and may even hamper their future development. Identifying the mode of action of the inhibitors greatly helps to prioritise compounds for further development as novel antimalarials. Here we describe a whole-cell method to detect inhibitors of the mitochondrial electron transport chain, using oxygen consumption as high throughput readout in 384-well plate format. The usefulness of the method has been confirmed with the Tres Cantos Antimalarial Compound Set (TCAMS). The assay identified 124 respiratory inhibitors in TCAMS, seven of which were novel anti-plasmodial chemical structures never before described as mitochondrial inhibitors. Keywords: Plasmodium falciparum, Plasmodium yoelii, Oxygen consumption, Mitochondrial inhibitors and cytochrome |
url |
http://www.sciencedirect.com/science/article/pii/S2211320717301203 |
work_keys_str_mv |
AT mariaggomezlorenzo functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT anerodriguezalejandre functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT soniamolinercubel functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT mariamartinezhoyos functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT noemibahamontesrosa functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT rubengonzalezdelrio functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT carolinarodenas functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT jesusdelafuente functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT joseluislavandera functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT josefgarciabustos functionalscreeningofselectivemitochondrialinhibitorsofplasmodium AT alfonsomendozalosana functionalscreeningofselectivemitochondrialinhibitorsofplasmodium |
_version_ |
1725741475041378304 |